FeesSafety
Pluang+

Medtronic to acquire Contego Medical for $380M to expand carotid artery and vascular disease treatments.

Company Fundamentals
16 Nov 2026, 13:45 WIB
PRNewsWire
View Source
Bullish
Medtronic to acquire Contego Medical for $380M to expand carotid artery and vascular disease treatments.

Medtronic announced its plan to acquire Contego Medical, a company specializing in carotid artery and peripheral thrombectomy devices, for $380 million. This acquisition will enhance Medtronic's portfolio with Contego's innovative Neuroguard IEP Direct System and Excipio thrombectomy devices, improving treatment options for carotid artery disease and peripheral vascular disease. The deal builds on their existing U.S. distribution partnership and aims to strengthen Medtronic's leadership in carotid revascularization. The acquisition is expected to close in Medtronic's fiscal Q3, with minimal impact on earnings in the near term and positive effects thereafter.

Medtronic's acquisition of Contego Medical highlights its strategic push in carotid and peripheral vascular therapies. On Pluang, Medtronic (MDT) shares trade at USD 103.27, up 0.40% as of Nov 16, 2026, 18:41 WIB, maintaining a strong market cap of $131.57 billion. The stock remains near its 52-week high of $105.35, reflecting steady investor interest in the health sector.

More News (MDT)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App